David W. Anstice is a retired senior executive and company director, working globally, and based in Pennsylvania, USA. He retired as a senior executive of Merck & Co., Inc., in September 2008, after a 35 year career. He had reported to Merck’s CEO, in various assignments, including President, The Americas; President, Asia Pacific; and President, Japan, since 1994. Prior to that date he was President of Merck’s European business. Merck is a world leader in the discovery, development, manufacture and marketing of prescription medicines and vaccines. He served on Merck’s Executive Committee, the Company’s senior management team, commencing in 1990.
Today, he is a non-executive Director of two public companies, CSL Limited, based in Melbourne, Australia (ASX), and Alkermes Plc, based in Dublin, Ireland (NASDAQ).
David is also Chairman and President of the University of Sydney USA Foundation (a USA based education fund raising group). He was awarded an Honorary Fellowship of the University of Sydney in 2007. He is Deputy Chairman and a member of the Board of the United States Studies Centre at the University of Sydney. He is a Member of the United States Advisory Council of the American Australian Association in New York. He is a member of the Board of the US Foundation of the University of the Valley of Guatemala, and the Board of the Friends of the Garvan (US). He is an Adjunct Professor at the Business School at the University of Sydney.
Born in Wagga Wagga, and an Economics graduate of the University of Sydney in Australia, Mr Anstice joined Merck in 1974, in Australia. He progressed through a series of positions, and on several continents, including Managing Director, Merck Sharp & Dohme Australia; Vice President, International Human Health Marketing, Merck Sharp & Dohme International; President, U.S. Human Health; President, Human Health Europe; President, Human Health, The Americas; from 2000 until July 2006, he was responsible for Merck’s joint ventures with Schering-Plough, and from January 2002 to July 2005 he was responsible for Merck’s human health businesses in Canada, Latin America, Japan, Australia and New Zealand, and until September 2006, Mr Anstice was President, Asia Pacific Human Health, responsible for Japan, China, Australia, Korea, and other Asia Pacific country human health pharmaceutical business of Merck & Co., Inc. During 2007, he acted as President, Global Human Health; and President, Banyu Pharmaceuticals, responsible for all Merck’s business in Japan, on short term assignments.
He served as Chairman of the National Pharmaceutical Council, Reston, Virginia in 1997, and represented Merck on the Board of Directors, and Executive Committee, of the Biotechnology Industry Organization in Washington, DC from 1996 to 2005.
He resides in Montgomery County, Pennsylvania, with his wife, Ana-Maria Zaugg.